LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort.

Yang, Mei / Meng, Yuan / Hao, Wudi / Zhang, Jin / Liu, Jianhua / Wu, Lina / Lin, Baoxu / Liu, Yong / Zhang, Yue / Yu, Xiaojun / Wang, Xiaoqian / Gong, Yu / Ge, Lili / Fan, Yan / Xie, Conghong / Xu, Yiyun / Chang, Qing / Zhang, Yixiao / Qin, Xiaosong

International immunopharmacology

2024  Volume 131, Page(s) 111829

Abstract: Background: Following the COVID-19 pandemic, studies have identified several prevalent characteristics, especially related to lymphocyte subsets. However, limited research is available on the focus of this study, namely, the specific memory cell subsets ...

Abstract Background: Following the COVID-19 pandemic, studies have identified several prevalent characteristics, especially related to lymphocyte subsets. However, limited research is available on the focus of this study, namely, the specific memory cell subsets among individuals who received COVID-19 vaccine boosters and subsequently experienced a SARS-CoV-2 breakthrough infection.
Methods: Flow cytometry (FCM) was employed to investigate the early and longitudinal pattern changes of cellular immunity in patients with SARS-CoV-2 breakthrough infections following COVID-19 vaccine boosters. XGBoost (a machine learning algorithm) was employed to analyze cellular immunity prior to SARS-CoV-2 breakthrough, aiming to establish a prognostic model for SARS-CoV-2 breakthrough infections.
Results: Following SARS-CoV-2 breakthrough infection, naïve T cells and T
Conclusion: SARS-CoV-2 breakthrough infection leads to disturbances in cellular immunity. Assessing cellular immunity prior to breakthrough infection serves as a valuable prognostic tool for SARS-CoV-2 infection, which facilitates clinical decision-making.
MeSH term(s) Humans ; COVID-19 Vaccines ; COVID-19 ; SARS-CoV-2 ; Breakthrough Infections ; Pandemics ; Prognosis ; Prospective Studies ; Tumor Necrosis Factor-alpha ; Immunity, Cellular ; Antibodies, Viral
Chemical Substances COVID-19 Vaccines ; Tumor Necrosis Factor-alpha ; Antibodies, Viral
Language English
Publishing date 2024-03-14
Publishing country Netherlands
Document type Journal Article
ZDB-ID 2043785-7
ISSN 1878-1705 ; 1567-5769
ISSN (online) 1878-1705
ISSN 1567-5769
DOI 10.1016/j.intimp.2024.111829
Shelf mark
Zs.A 5408: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top